BRIANNA JACKSON: Open Payments
NPI 1922679489 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,778 in 99 payments from 21 companies in 2025. Trend: 2023 $40 · 2024 $1,492 · 2025 $2,778
Food & beverage: $2,778
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $811 |
| AstraZeneca Pharmaceuticals LP | 11 | $444 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $297 |
| Lilly USA, LLC | 6 | $217 |
| PFIZER INC. | 7 | $166 |
| Gilead Sciences, Inc. | 4 | $159 |
| Vanda Pharmaceuticals Inc. | 6 | $126 |
| Aimmune Therapeutics, Inc. | 5 | $102 |
| Astellas Pharma US Inc | 3 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
Products named: QULIPTA, AIRSUPRA, CAPLYTA, VRAYLAR, FANAPT, ZEPBOUND, Epclusa, ZENPEP.
Industry payments across WI — which companies pay providers there.
